Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Germany”
Sponsor: University Hospital, Limoges
Amyotrophic Lateral Sclerosis
France, Germany
Sponsor: BeOne Medicines
Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma
United States, Argentina, Australia, Austria, Belgium +19 more
Sponsor: Incyte Corporation
Solid Tumors
United States, Australia, Austria, Belgium, Canada +15 more
- Study of Plozasiran in Adults With Severe HypertriglyceridemiaActive Not Recruiting
Sponsor: Arrowhead Pharmaceuticals
Severe Hypertriglyceridemia
United States, Argentina, Brazil, Bulgaria, Canada +11 more
Sponsor: Jena University Hospital
Stable Angina
Germany
Sponsor: Hoffmann-La Roche
Hemophilia A
United States, Germany, Hungary, Italy, Japan +5 more
- Longitudinal Multimodal Response Assessment During Neoadjuvant Treatment of Rectal CancerActive Not Recruiting
Sponsor: Jena University Hospital
Locally Advanced Rectal Carcinoma · Neoadjuvant Treatment · Radiotherapy · Adaptive Treatment
Germany
Sponsor: Incyte Corporation
Hidradenitis Suppurativa (HS)
United States, Argentina, Australia, Austria, Belgium +15 more
Sponsor: Eli Lilly and Company
Lymphoma, Non-Hodgkin's · Lymphoma, Diffuse Large B-Cell · Follicular Lymphoma
United States, France, Germany, Italy, Japan +3 more
Sponsor: Incyte Corporation
Myeloproliferative Neoplasms
United States, Australia, Belgium, Germany, Italy
Sponsor: AstraZeneca
Relapsed Refractory Multiple Myeloma
United States, Australia, Brazil, Canada, China +10 more
Sponsor: Greenwich LifeSciences, Inc.
Breast Cancer
United States, Belgium, France, Germany, Ireland +5 more
Sponsor: Jena University Hospital
Intracranial Hemorrhages · Atrial Fibrillation (AF) · Atrial Flutter
Germany, Poland
Sponsor: Wuerzburg University Hospital
Young Healthy Adults
Germany
Sponsor: Amgen
Active Juvenile Psoriatic Arthritis
Austria, Belgium, France, Germany, Greece +10 more
Sponsor: Boehringer Ingelheim
Obesity · Diabetes Mellitus, Type 2
United States, Australia, Belgium, Canada, China +14 more
- Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC)Active Not Recruiting
Sponsor: AstraZeneca
Non-Small-Cell Lung Carcinoma NSCLC
United States, Australia, Belgium, Canada, France +12 more
- A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Muscle-invasive Urothelial Carcinoma
United States, Argentina, Australia, Canada, Denmark +10 more
Sponsor: Eli Lilly and Company
Atherosclerosis Cardiovascular Disease · Chronic Kidney Disease
Argentina, Australia, Austria, Belgium, Brazil +33 more
Sponsor: Jasper Therapeutics, Inc.
Chronic Spontaneous Urticaria
United States, Germany
- Fit to Fight Childhood CancerRecruiting
Sponsor: Johannes Gutenberg University Mainz
Pediatric Oncology
Germany
Sponsor: Hoffmann-La Roche
Alzheimers Disease
United States, Argentina, Brazil, Canada, China +8 more
Sponsor: Sanofi
Chronic Spontaneous Urticaria
Argentina, Canada, Chile, Germany, Greece +8 more
- A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Multiple Sclerosis
United States, Argentina, Brazil, France, Germany +4 more
Sponsor: Merck Sharp & Dohme LLC
Hypercholesterolemia · Familial Hypercholesterolemia
United States, Argentina, China, Colombia, Germany +9 more